[go: up one dir, main page]

SV2002000640A - Sistema de transfeccion intensificada ref.msb-7270-sv - Google Patents

Sistema de transfeccion intensificada ref.msb-7270-sv

Info

Publication number
SV2002000640A
SV2002000640A SV2001000640A SV2001000640A SV2002000640A SV 2002000640 A SV2002000640 A SV 2002000640A SV 2001000640 A SV2001000640 A SV 2001000640A SV 2001000640 A SV2001000640 A SV 2001000640A SV 2002000640 A SV2002000640 A SV 2002000640A
Authority
SV
El Salvador
Prior art keywords
msb
intensified
protein
transfection system
system ref
Prior art date
Application number
SV2001000640A
Other languages
English (en)
Inventor
Helena Yee
Myung-Sam Cho
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of SV2002000640A publication Critical patent/SV2002000640A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN SISTEMA VECTOR DE EXPRESION GENICA EN CELULAS DE MAMIFEROS QUE INCLUYE UNA PLURALIDAD DE PLASMIDOS Y COMPRENDE:a) UN SISTEMA DE MANTENIMIENTO EPISOMAL;b) UN FUERTE PROMOTOR/INTENSIFICADOR;c) UN COMPLEJO DE TRANSACTIVACION DE PROTEINAS Yd) ADN QUE CODIFICA PARA LA PROTEINA HETEROLOGA.LOS COMPLEJOS DE MANTENIMIENTO EPISOMAL Y DE TRASACTIVACION DE PROTEINAS PUEDEN INCLUIR SUBELEMENTOS SITUADOS EN EL MISMO O EN DIFERENTES PLASMIDOS DENTRO DEL SISTEMA DE EXPRESION CELULAR
SV2001000640A 2000-09-28 2001-09-27 Sistema de transfeccion intensificada ref.msb-7270-sv SV2002000640A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67584700A 2000-09-28 2000-09-28

Publications (1)

Publication Number Publication Date
SV2002000640A true SV2002000640A (es) 2002-10-24

Family

ID=24712193

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000640A SV2002000640A (es) 2000-09-28 2001-09-27 Sistema de transfeccion intensificada ref.msb-7270-sv

Country Status (18)

Country Link
EP (1) EP1356069B1 (es)
JP (1) JP5022555B2 (es)
AR (1) AR035495A1 (es)
AU (1) AU2001289075A1 (es)
CA (1) CA2420771C (es)
CO (1) CO5270027A1 (es)
DE (1) DE60119386T2 (es)
DO (1) DOP2001000254A (es)
EC (1) ECSP014147A (es)
ES (1) ES2263652T3 (es)
GT (1) GT200100194A (es)
HN (1) HN2001000215A (es)
MY (1) MY139948A (es)
PE (1) PE20030412A1 (es)
SV (1) SV2002000640A (es)
TW (1) TWI239354B (es)
UY (1) UY26947A1 (es)
WO (1) WO2002027005A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006121995A (ja) * 2004-10-29 2006-05-18 Tokyo Medical & Dental Univ Ｅｂｎａ１変異体
CN101341252B (zh) 2005-10-28 2011-08-17 弗·哈夫曼-拉罗切有限公司 啮齿动物细胞中的蛋白质表达
ES2699718T3 (es) 2009-09-15 2019-02-12 Medlmmune Ltd Células para expresión transitoria y usos de las mismas
WO2014092094A1 (ja) * 2012-12-11 2014-06-19 タカラバイオ株式会社 発現カセット

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9003010D0 (en) * 1990-02-09 1990-04-04 Glaxo Group Ltd Gene expression in yeast cells
US6150515A (en) * 1996-07-03 2000-11-21 Massachusetts Institute Of Technology Tat-SF: cofactor for stimulation of transcriptional elongation by HIV-1 Tat
US6465251B1 (en) * 1996-11-13 2002-10-15 Dana-Farber Cancer Institute, Inc. Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
DZ2788A1 (fr) * 1998-05-15 2003-12-01 Bayer Ag Agonistes et antagonistes selectifs à IL-2.
IT1302403B1 (it) * 1998-11-06 2000-09-05 Angeletti P Ist Richerche Bio Cellule per la produzione di vettori adenovirali difettivi, metodoper la loro preparazione e loro uso.
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression

Also Published As

Publication number Publication date
WO2002027005A3 (en) 2003-07-31
AR035495A1 (es) 2004-06-02
DE60119386T2 (de) 2007-04-19
TWI239354B (en) 2005-09-11
JP5022555B2 (ja) 2012-09-12
GT200100194A (es) 2002-05-16
DE60119386D1 (de) 2006-06-08
JP2004509642A (ja) 2004-04-02
WO2002027005A9 (en) 2003-02-06
UY26947A1 (es) 2002-04-26
CO5270027A1 (es) 2003-04-30
EP1356069B1 (en) 2006-05-03
CA2420771C (en) 2010-12-21
CA2420771A1 (en) 2002-04-04
DOP2001000254A (es) 2002-06-15
HN2001000215A (es) 2003-11-11
PE20030412A1 (es) 2003-06-26
ES2263652T3 (es) 2006-12-16
WO2002027005A2 (en) 2002-04-04
MY139948A (en) 2009-11-30
ECSP014147A (es) 2002-05-23
EP1356069A2 (en) 2003-10-29
AU2001289075A1 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
ES2056817T5 (es) Transformacion de trichoderma.
ES2086552T3 (es) Biosensor electroquimico estable.
ES2134022T3 (es) Composiciones cosmeticas a base de policondensados ionizables multisecuenciados polisiloxano/poliuretano y/o poliurea en solucion y utilizaciones.
ES2095239T3 (es) Aparato de desfibrilacion por envio de descargas basadas en la longitud de ciclo de fibrilacion.
NL180420B (nl) Farmaceutische preparaten, welke een invloed op de maagzuurafscheiding bezitten en ten minste een guanidinothiazoolderivaat als werkzame stof bevatten alsmede de voor gebruik in dergelijke preparaten geschikte guanidinothiazoolderivaten.
ES2188929T3 (es) Analogos 2-peptidicos de tipo glucagon.
ES2195664T3 (es) Uso de fumaratos de dialquilo.
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
NL930103I2 (nl) Nonapeptide- en decapeptidederivaten van tot afgifte van luteiniserend hormoon aanzettend hormoon, bereiding daarvan en farmaceutische preparaten, di e deze bevatten.
ES2191031T3 (es) Proteinas intracelulares de enlace (pil) y sus utilizaciones.
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
DK585886D0 (da) Immunstimulerende middel og anvendelse deraf
ES2080800T3 (es) Polipeptidos y analogos de polipeptidos con actividad inhibitoria frente a la elastasa humana.
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
ES2176216T3 (es) Particulas de ceramica y su preparacion.
SV2002000640A (es) Sistema de transfeccion intensificada ref.msb-7270-sv
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2034953T3 (es) Un procedimiento para la preparacion de una tiazolona.
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2185698T3 (es) Composicion de tratamiento anti-acne de la piel.
FR2159M (fr) Nouveaux stéroides physiologiquement actifs.
ES2164907T3 (es) Secuencias reguladoras del gen cd4 y su expresion especifica en los linfocitos t maduros.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
ES2181667T3 (es) Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.

Legal Events

Date Code Title Description
FA Abandonment
FG Grant